Search Results - "Groh, M A"

Gαi Proteins are Indispensable for Hearing by Beer-Hammer, Sandra, Lee, Sze Chim, Mauriac, Stephanie A., Leiss, Veronika, Groh, Isabel A. M., Novakovic, Ana, Piekorz, Roland P., Bucher, Kirsten, Chen, Chengfang, Ni, Kun, Singer, Wibke, Harasztosi, Csaba, Schimmang, Thomas, Zimmermann, Ulrike, Pfeffer, Klaus, Birnbaumer, Lutz, Forge, Andrew, Montcouquiol, Mireille, Knipper, Marlies, Nürnberg, Bernd, Rüttiger, Lukas

“…Background/Aims: From invertebrates to mammals, Gα i proteins act together with their common binding partner Gpsm2 to govern cell polarization and planar…”
Get full text

Port-access coronary artery bypass grafting: technique and comparative results by Groh, Mark A, Sutherland, Susan E, Burton, Harry G, Johnson, Alan M, Ely, Stephen W

“…Background. Interest in minimally invasive coronary artery bypass grafting (CABG) continues to grow, and the techniques evolve. Our study examines the…”
Get full text

Results of a prospective multicenter study on port-access coronary bypass grafting by Grossi, Eugene A, Groh, Mark A, Lefrak, Edward A, Ribakove, Greg H, Albus, Robert A, Galloway, Aubrey C, Colvin, Stephen B

“…Background. We reviewed the initial patient series of three institutions performing large volume port-access (PA) coronary artery bypass grafting (CABG) to…”
Get full text

Impact of Alternaria toxins on CYP1A1 expression in different human tumor cells and relevance for genotoxicity by Pahlke, G., Tiessen, C., Domnanich, K., Kahle, N., Groh, I.A.M., Schreck, I., Weiss, C., Marko, D.

“…•CYP1A induction by alternariol is AhR-dependent.•CYP1A induction by alternariol has no substantial impact on genotoxicity.•ATX-II acts as an inducer of CYP1A…”
Get full text

Myocardial contractility in a canine model of the brain-dead organ donor by Huber, T S, Groh, M A, Gallagher, K P, D'Alecy, L G

“…To test the hypothesis that the induction and maintenance of brain death leads to a decrease in myocardial contractility. Prospective, randomized, controlled…”
Get more information

Repair of tetralogy of Fallot in infancy. Effect of pulmonary artery size on outcome by Groh, M A, Meliones, J N, Bove, E L, Kirklin, J W, Blackstone, E H, Lupinetti, F M, Snider, A R, Rosenthal, A

“…The possible influence of small pulmonary artery size on the results following complete repair of tetralogy of Fallot has not been investigated in patients…”
Get full text

The effect of intramyocardial pH on functional recovery in neonatal hearts receiving St. Thomas' Hospital cardioplegic solution during global ischemia by Iannettoni, M D, Bove, E L, Fox, M H, Groh, M A, Bolling, S F, Gallagher, K P

“…The experiments in the present study were designed to address two issues: Is it possible to manipulate intramyocardial pH in neonatal hearts with different…”
Get more information

Acadesine (AICA-riboside) improves postischemic cardiac recovery by Bolling, Steven F., Groh, Mark A., Mattson, Ann M., Grinage, Russell A., Gallagher, Kim P.

“…To test if acadesine (5-aminoimidazole-4-carboxamide riboside), a purine precursor, has cardioprotective effects, 16 dogs were placed on total cardiopulmonary…”
Get full text

First report of the port access international registry by Galloway, Aubrey C, Shemin, Richard J, Glower, Donald D, Boyer, Joseph H, Groh, Mark A, Kuntz, Richard E, Burdon, Thomas A, Ribakove, Greg H, Reitz, Bruce A, Colvin, Stephen B

“…Background. For minimally invasive cardiac operations to be widely applicable, the risks must be equivalent to those of standard open-chest operations. This…”
Get full text

Removal of an infected right atrial mass in a patient with sickle cell disease by Spotnitz, William D., Dent, John M., Mintz, Paul D., Erickson, Nicholette L., Fechner, Robert E., Groh, Mark A.

“…The use of indwelling central catheters for hyperalimentation, chemotherapy, and long-term venous access is increasing. We report the successful removal of an…”
Get full text

Early postoperative morbidity after surgical treatment of thyroid carcinoma by van Heerden, J A, Groh, M A, Grant, C S

“…The long-term results after operations for malignant thyroid conditions are well known. Less well known are figures on early postoperative morbidity and…”
Get more information

Port-Access ™ Coronary Artery Bypass Grafting: Technical Strategies for Multivessel Complete Revascularization by Groh, Mark A.

“…Complete coronary artery revascularization results in improved symptom‐free survival. Standard cardiac revascularization uses cardiac arrest for microvascular…”
Get full text

Alteration of the Traditional Extracorporeal Bypass Circuit to Accommodate Port-Access Minimally Invasive Cardiac Procedures Using Endovascular Based Cardiopulmonary Bypass by Groh, Mark A., Fallen, David M.

“…Port‐Access minimally invasive cardiac surgery systems (Heartport, Inc., Redwood City, CA, U.S.A.) enable surgeons to perform many procedures including valve…”
Get full text

Corrigendum to “Methyleugenol and selected oxidative metabolites affect DNA-Damage signalling pathways and induce apoptosis in human colon tumour HT29 cells” [ Food Chem. Toxicol. 108 (2017) 267–275] by Groh, I.A.M., Esselen, M.

Get full text

Port-access cardiac surgery protocols and early outcomes by Rogers, J P, Novchich, T M, Pearce, G L, Johnston, J S, Burton, 3rd, H G, Groh, M A

“…As a new cardiac surgical procedure, port-access holds promise to significantly impact the surgical approaches for treatment of CAD. Supporting collaborative…”
Get more information

Ambulatory intraaortic balloon counterpulsation by Buchanan, Scott A., Langenburg, Scott E., Mauney, Michael C., Blackbourne, Lorne H., Groh, Mark A., Bergin, James D., Tribble, Curtis G.

“…A technique is described for the retroperitoneal placement of a balloon pump that preserves patient mobility. This technique may be superior to standard…”
Get full text

Midterm, multicenter clinical and hemodynamic results for the Trifecta aortic pericardial valve by Goldman, Scott, MD, Cheung, Anson, MD, Bavaria, Joseph E., MD, Petracek, Michael R., MD, Groh, Mark A., MD, Schaff, Hartzell V., MD

“…Abstract Objective To evaluate the midterm hemodynamic performance and clinical outcomes of the Trifecta aortic pericardial valve. Methods In a multicenter,…”
Get full text

The St Jude Medical Trifecta aortic pericardial valve: Results from a global, multicenter, prospective clinical study by Bavaria, Joseph E., MD, Desai, Nimesh D., MD, PhD, Cheung, Anson, MD, Petracek, Michael R., MD, Groh, Mark A., MD, Borger, Michael A., MD, Schaff, Hartzell V., MD

“…Background The St Jude Medical Inc (St Paul, Minn) Trifecta valve is a novel aortic biological prosthesis that incorporates several design features, including…”
Get full text

Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator by Groh, Christopher A., MD, Sharma, Shishir, MD, Pelchovitz, Daniel J., MD, Bhave, Prashant D., MD, Rhyner, John, MD, Verma, Nishant, MD, Arora, Rishi, MD, Chicos, Alexandru B., MD, Kim, Susan S., MD, Lin, Albert C., MD, Passman, Rod S., MD, FHRS, Knight, Bradley P., MD, FHRS

“…Background An electrocardiographic (ECG) screening test has been developed to identify patients being considered for a totally subcutaneous implantable…”
Get full text

Is Surgical Intervention the Optimal Therapy for the Treatment of Aortic Valve Stenosis for Patients With Intermediate Society of Thoracic Surgeons Risk Score? by Groh, Mark A., MD, Diaz, Ivan, PhD, Johnson, Alan M., MD, Ely, Stephen W., MD, PhD, Binns, Oliver A., MD, Champsaur, Gerard L., MD

“…Background Patients at intermediate risk (IR) according to The Society of Thoracic Surgeons risk score are today frequently oriented toward the transfemoral…”
Get full text